Lechuang Chen

603 citations
15 papers · 481 indexed · h-index 13

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Immune cells in cancer
    • Immune Cell Function and Interaction

Papers in

Lechuang Chen

15 papers receiving 476 citations

Peers

Lechuang Chen
Comparison fields: 5 of 76
  • Cancer Research 93
  • Immunology 125
  • Virology 22
  • Molecular Biology 280
  • Oncology 99
Replace Vitalba Ruggieri with:
Vitalba Ruggieri Italy
Andrew Herman United Kingdom
Federica Barchiesi Switzerland
Theresa J. Barberi United States
Nicole Bacher Austria
Wen‐Cheng Chou Taiwan
Xiaojun Meng China
Pamela A. Hankey United States
Anastasia A. Khutornenko Russia
Lechuang Chen relative to Vitalba Ruggieri Italy Vitalba Ruggieri's profile →
Citations per field
00.5×1.5×1.9×
Vitalba Ruggieri · 1×
Citations per year

Countries citing papers authored by Lechuang Chen

Since Specialization
Citations

This map shows the geographic impact of Lechuang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lechuang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lechuang Chen more than expected).

Fields of papers citing papers by Lechuang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lechuang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lechuang Chen. The network helps show where Lechuang Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Lechuang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lechuang Chen Line = papers co-authored together Lechuang Chen links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 202215
2 20226
3 202212
4 202023
5 201923
6 201867
7 201889
8 201620
9 201627
10 201628
11 201654
12 201533
13 201420
14 201431
15 201233

About Lechuang Chen

Lechuang Chen is a scholar working on Cell Biology, Complementary and alternative medicine, Cancer Research, Oncology and Molecular Biology, having authored 15 papers that have together received 481 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (3 papers), Immune cells in cancer (3 papers), Kruppel-like factors research (3 papers), Epigenetics and DNA Methylation (2 papers), MicroRNA in disease regulation (2 papers), Natural Compounds in Disease Treatment (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Cancer Research (93 citations), Immunology (125 citations), Virology (22 citations), Molecular Biology (280 citations) and Oncology (99 citations). Lechuang Chen has collaborated with scholars based in China and United States. Frequent co-authors include Hongxia Zhu, Ningzhi Xu, Kai Ma, Chenfei Hu, Shufang Liang, Shuren Wang, Qing Xu, Mei Liu, Mei Liu and Zaozao Wang. Their work appears in journals such as Oncotarget, Bioscience Reports, PLoS ONE, Scientific Reports and Molecular Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026